Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kineticsMie Fabricius Pedersen, Hans Bräuner‐Osborne, Federica Gabriele et al.|Neuropharmacology|2019Cited by 81
The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOHAnders A. Jensen, Jesper L. Kristensen, Nikolaj Speth et al.|Biochemical Pharmacology|2020Cited by 25
Probing the Existence of a Metastable Binding Site at the β <sub>2</sub> -Adrenergic Receptor with Homobivalent Bitopic LigandsBirgit I. Gaiser, Daniel Sejer Pedersen, Emil Märcher-Rørsted et al.|Journal of Medicinal Chemistry|2019Cited by 17